The aim of the study was to assess the level of anxiety and depressiveness in patients who had qualified for hyperbaric oxygen therapy (HBOT) for the treatment of ulcerative lesions in the lower limbs, occurring as a result of diabetic foot syndrome (DFS),. A total of 50 patients with type 2 diabetes and diabetic foot syndrome were enrolled to the study. All patients have received 30 sessions of HBOT. During the therapy blood glucose was measured and photographic documentation was carried out. All patients underwent the following procedures: medical history and socioeconomic interview, psychiatric examination, self-report and objective psychometric tests to measure anxiety and depressiveness. Based on the obtained results, we reported that patients with a greater degree of tissue damage had higher levels of depressive symptoms in the self-report tests as well as in the objective evaluation of the investigator. In terms of location of ulcerative lesions - the level of depressiveness was greater when the affected area included toes, and the level of anxiety was increased when it concerned the heel. Regarding other parameters, statistically significant correlations were not observed.
1. Al-Waili NS, Butler GJ, Beale J et al. Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease. Adv Ther 2005; 22: 659–678.
2. Al-Waili NS, Butler GJ, Beale J et al. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 2005; 11: RA279–RA289;
3. Cao H, Ju K, Zhong L, Meng T. Efficacy of hyperbaric oxygen treatment for depression in the convalescent stage following cerebral hemorrhage. Exp Ther Med. 2013 Jun;5(6):1609-1612;
4. Yan D, Shan J, Ze Y, Xiao-Yan Z, Xiao-Hua H. The effects of combined hyperbaric oxygen therapy on patients with post-stroke depression. J Phys Ther Sci. 2015 May;27(5):1295-7;
5. Moussavi S, Chatterji S, Verdes E. et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 2007, 370, 851-58;
6. van Dooren FEP, Nefs G, Schram MT, Verhey FRJ, Denollet J, et al. (2013) Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS ONE 8(3): e57058;
7. Cole-King A, Harding KG. Psychological factors and delayed healing in chronic wounds. Psychosom Med. 2001 Mar-Apr;63(2):216-20;
8. Tatoń J. Guidebook for individuals with type 2 diabetes not requiring insulin treatment. Wydawnictwo Lekarskie PZWL, Warsaw, 2002;
9. Megitt B. Surgical management of the diabetic foot. Br. J. Hosp. Med. 1976;227,216;
10. Wagner W. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2,64;
11. Tomaszewski K, Zarychta M, Bieńkowska A, Chmurowicz E, Nowak W, Skalska A. Validation of the Polish language version of Patient Health Questionnaire-9 in the population of hospitalised elderly. Psychiatria Polska 2011, vol. XLV, no. 2 pp. 223–233;
12. Wichowicz H, Wieczorek D. Screening tests for post-stroke depression with the use of Hospital Anxiety and Depression Scale (HADS) Psychiatria Polska 2011, vol. XLV, no. 4, pp. 505–514;
13. Łoza B. How to simultaneously measure anxiety and depression? Hospital Anxiety and Depression Scale. Wiadomości Psychiatryczne, vol. 14, no. 4/2011, pp. 225-230;
14. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5;
15. Kotapka-Minc S. The importance of neuropsychological examination in the diagnosis of dementia. Polski Przegląd Neurologiczny 2007, vol. 3, 2, pp. 61–68;
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960; 23: 56–62;
17. Schmitt J, Ford D. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approach General Hospital Psychiatry 29 (2007) 134–140;
18. Menzies V. Depression and Burn Wounds. Archives of Psychiatric Nursing, Vol. XIV, No. 4;
19. Bradley C, Lewis S. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet. Med., 1990, 7, 5, 445-451;
20. Lloyd E, Dyer H, Barnett A. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet. Med., 2000, 17, 198-202;
21. Cao H, Ju K, Zhong L, Meng T. Efficacy of hyperbaric oxygen treatment for depression in the convalescent stage following cerebral hemorrhage. Exp Ther Med. 2013 Jun;5 (6):1609-1612;
22. Yan D, Shan J, Ze Y, Xiao-Yan Z. The effects of combined hyperbaric oxygen therapy on patients with post-stroke depression. J Phys Ther Sci. 2015 May;27(5):1295-7.